| Precision Dosing of Oral Ibuprofen for PDA, A Pilot RCT (NCT07143201) | Hamilton Health Sciences Corporation | 2024-07-04 |
| Repurposing Lithium for Parkinson's Disease: a RCT (NCT06339034) | State University of New York at Buffalo | 2024-07-03 |
| Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy (NCT06529029) | Michigan State University | 2024-07-03 |
| Clinical Trial of VIM With VIT in Children With Relapsed and Refractory Soft Tissue Sarcoma. (NCT06514313) | Yizhuo Zhang | 2024-07-03 |
| Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma (NCT05932199) | Baylor College of Medicine | 2024-07-03 |
| Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma (NCT06093061) | National Cancer Centre, Singapore | 2024-07-03 |
| PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer (NCT06392295) | University of Miami | 2024-07-03 |
| AK104 and Low-dose Radiation in Recurrent/Metastatic HNSCC After Failure of First-line Systemic Therapy (NCT06494995) | Fudan University | 2024-07-03 |
| Study of Radiation Therapy in Combination With Darolutamide + Degarelix in Intermediate Risk Prostate Cancer (NCT04176081) | University Health Network, Toronto | 2024-07-02 |
| Study of WAL0921 in Patients With Glomerular Kidney Diseases (NCT06466135) | Walden Biosciences | 2024-07-02 |
| Step Up for STEM and Health Careers (NCT06445751) | Ohio State University | 2024-07-02 |
| Olanzapine Impact on First-line Immunotherapy for Advanced EGFR-negative NSCLC (NCT06554613) | Second Affiliated Hospital of Nanchang University | 2024-07-02 |
| Sildenafil for Microvasculopathy in Chronic TBI (NCT05782244) | University of Pennsylvania | 2024-07-02 |
| A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors (NCT06474455) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2024-07-02 |
| Testing the Efficacy of Topical Calcipotriene Plus 5-Fluorouracil Combination to Activate the Immune System Against Precancerous Skin Lesions in Organ Transplant Recipients (NCT05699603) | University of Arizona | 2024-07-02 |
| RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis (NCT06328777) | Cabaletta Bio | 2024-07-02 |
| SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers (NCT05846789) | Kathy Miller | 2024-07-02 |
| Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease (NCT06293365) | Novartis Pharmaceuticals | 2024-07-02 |
| Study of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa (NCT06591793) | AAVantgarde Bio Srl | 2024-07-02 |
| Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML. (NCT06483906) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2024-07-02 |
| Phase II Study of Post-Transplant Low-Dose Inotuzumab Ozogamicin to Prevent Relapse of Acute Lymphoblastic Leukemia (NCT06427330) | Institute of Hematology & Blood Diseases Hospital, China | 2024-07-02 |
| A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Severe AADC Deficiency (NCT06432140) | Shanghai Vitalgen BioPharma Co., Ltd. | 2024-07-02 |
| Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia (NCT06471218) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2024-07-02 |
| A Phase I/II Trial to Assess the Efficacy and Toxicity of ASTX727 (Oral Decitabine/Cedazuridine) for the Treatment of Hematological Neoplasms After Allogeneic Stem Cell Transplantation (NCT06297629) | M.D. Anderson Cancer Center | 2024-07-01 |
| PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC (NCT06102057) | TheraOp | 2024-07-01 |
| Efficacy and Safety of Hydroxychloroquine in the Treatment of Sudden Sensorineural Hearing Loss (NCT06467526) | Chang Gung Memorial Hospital | 2024-07-01 |
| Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells) in Children and Adolescents (NCT05013983) | WestVac Biopharma Co., Ltd. | 2024-07-01 |
| Eculizumab for Prevention of Antibody-Mediated Rejection in ABO-Incompatible Living Donor Kidney Transplantation (NCT06453135) | Tao Lin | 2024-07-01 |
| Chinese Herbal Medicine for Gynecologic Patients (NCT06187376) | Icahn School of Medicine at Mount Sinai | 2024-07-01 |
| First-Line Treatment Induced With mFOLFOX6 and HLX04 Regimen, Following Combined With Serplulimab in MSS Initially Unresectable Metastatic Colorectal Cancer (NCT06491355) | Sir Run Run Shaw Hospital | 2024-07-01 |
| B-amyloid as a Marker for GBM Bioimaging (NCT05820191) | Universidad Central del Caribe | 2024-07-01 |
| Evaluating LP-10 in Subjects With OLP (NCT06233591) | Lipella Pharmaceuticals, Inc. | 2024-07-01 |
| PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab) (NCT06430736) | Insel Gruppe AG, University Hospital Bern | 2024-07-01 |
| DEB-TACE Combined With Apatinib and PD-1 for the Treatment of Intrahepatic Cholangiocarcinoma (NCT04834674) | Sichuan Cancer Hospital and Research Institute | 2024-07-01 |
| Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced HR-positive,HER2-negative BC. (NCT06705127) | First Affiliated Hospital of Zhejiang University | 2024-07-01 |
| Effectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal Antibody-Containing GVHD Prophylaxis Scheme to Reduce the Incidence of Severe Acute GVHD After Umbilical Cord Blood Transplantation for Malignant Hematologic Diseases (NCT06480630) | Anhui Provincial Hospital | 2024-07-01 |
| Study to Assess the Safety and Efficacy of Intravenous BSG005 in Patients With Invasive Fungal Infection (NCT06678113) | Biosergen AS | 2024-07-01 |
| VERIFY: Vedolizumab for the Prevention of Immune Checkpoint Inhibitor Related Diarrhea or Colitis in Patients With Cancer (NCT06337695) | University of Calgary | 2024-07-01 |
| Transvaginal Human Acellular Dermal Matrix for Prolapse Treatment (NCT06404931) | Hospital Mutua de Terrassa | 2024-07-01 |
| Neoadjuvant Intra-tumor Double Immunotherapy for Hepatocellular Carcinoma. (NCT06492408) | Second Affiliated Hospital of Guangzhou Medical University | 2024-07-01 |
| AG Combined With Cadonilimab Sequential Short-course Radiotherapy in the Treatment of Locally aPDAC (NCT06472037) | Tianjin Medical University Cancer Institute and Hospital | 2024-07-01 |
| A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma (NCT05624918) | Ashish Manne | 2024-07-01 |
| A Study of QL1706 (an Anti-PD-1/CTLA-4 Combined Antibody) Combined With Albumin-bound Paclitaxel and Bevacizumab in the Treatment of Platinum-resistant Recurrent Ovarian Cancer (NCT06509971) | West China Second University Hospital | 2024-07-01 |
| Characterization and Mechanism Research of the Pre-disease State of Obese Type 2 Diabetes Mellitus (NCT06495814) | Fengmei Lian | 2024-07-01 |
| GH21 Combined With D-1553 in KRAS G12C Mutant Advanced Solid Tumors (NCT06435455) | Suzhou Genhouse Bio Co., Ltd. | 2024-07-01 |
| Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer (NCT06527898) | Anhui Provincial Hospital | 2024-07-01 |
| Protocols for Magnesium Sulfate Maintenance Dose in Overweight and Obese Women Diagnosed With Preeclampsia (NCT06486025) | Ain Shams University | 2024-07-01 |
| Blinatumomab Maintenance After Allo-HSCT (NCT06438796) | Ruijin Hospital | 2024-07-01 |
| Evaluating Safety and Efficacy of Autologous Gene-edited Muscle Stem Cells (GenPHSats-bASKet) (NCT05588401) | Simone Spuler, MD | 2024-07-01 |
| Crizanlizumab Improves Tissue Oxygen Supply Demand Matching in Patients With Sickle Cell Anemia (NCT05469828) | Children's Hospital Los Angeles | 2024-07-01 |
| Quelling of Excitotoxicity in Acute Stroke With Ketamine (NCT03223220) | Lower Merion Neurology Research Foundation | 2024-07-01 |
| A Study Evaluating ANV600 Single Agent or in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (EXPAND-1) (NCT06470763) | Anaveon AG | 2024-07-01 |
| Efficacy of Oxfendazole in the Treatment of Trichuris Trichiura Infection in Adults (NCT03435718) | Oxfendazole Development Group | 2024-07-01 |
| MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA) (NCT06150417) | Case Comprehensive Cancer Center | 2024-07-01 |
| A Study of Auxora in Patients With AKI and Injurious Lung "Crosstalk" (NCT06374797) | CalciMedica, Inc. | 2024-07-01 |
| Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Stable Brain Metastasis (NCT06501391) | Fudan University | 2024-07-01 |
| Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Active Brain Metastasis (NCT06501378) | Fudan University | 2024-07-01 |
| A Study of ATB1651 in Adults With Mild to Moderate Onchomycosis (NCT06327295) | AmtixBio Co., Ltd. | 2024-07-01 |
| Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT (NCT07062523) | Peking Union Medical College Hospital | 2024-07-01 |
| The Effectiveness of Probiotics in Neonatal Jaundice (NCT06449508) | Tanta University | 2024-07-01 |
| A Study to Evaluate the Efficacy and Safety of the Combination of Glumetinib and Docetaxel（Albumin Bound）Verse Docetaxel for the Treatment of MET-overexpressed Non-small Cell Lung Cancer (NCT06525350) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2024-07-01 |
| Treatment of Neonatal Encephalopathy With Oral Sildenafil Suspension to Repair Brain Injury Secondary to Birth Asphyxia (NCT06098833) | Pia Wintermark | 2024-07-01 |
| Neoadjuvant Adebrelimab in Resectable SCLC: A Randomized Trial (NCT06485544) | Tang-Du Hospital | 2024-07-01 |
| A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis. (NCT06447597) | Shanghai Jiaolian Drug Research and Development Co., Ltd | 2024-07-01 |
| Pembrolizumab and Olaparib Treatment for Relapsed or Refractory Peripheral T-Cell Lymphoma (NCT06160843) | National Cancer Centre, Singapore | 2024-07-01 |
| Safety and Efficacy of Botulinum Toxin-A Injection Into Ischiocavernosus Muscle for Premature Ejaculation (NCT06851598) | Abdallah Mohamed Abdallah Mohamed Elgendy | 2024-07-01 |
| A Phase II Study of Neoadjuvant Immunotherapy in Combination With Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT06444009) | Lei Liu | 2024-07-01 |
| Cadonilimab(AK104) Plus Concurrent Chemoradiotherapy in Patients With Locally Advanced, Unresectable, Stage III NSCLC (NCT06448910) | Fudan University | 2024-07-01 |
| MSC Exosome Therapy for Post-Preeclampsia Endothelial Dysfunction (NCT07183384) | Universitas Padjadjaran | 2024-07-01 |
| A Study to Evaluate the Efficacy of Osimertinib in Patients With EGFR-sensitive Mutated Non-small Cell Lung Cancer Progression After Receiving Adjuvant Targeted Therapy Following Radical Surgery (NCT06530719) | Jin Ying | 2024-07-01 |
| Dexmedetomidine Sublingual Film for the Ambulatory Treatment of Hyperadrenergic Autonomic Crisis in Patients With Familial Dysautonomia (NCT06148311) | NYU Langone Health | 2024-07-01 |
| Comparison Between Effect of Empirical Antibiotic Prophylaxis Versus Enhanced Prophylactic Measures on Rate of Urinary Tract Infection After Flexible Ureteroscopy in Children With Pyuria (NCT07229755) | Ain Shams University | 2024-07-01 |
| Sirolimus for Improving Social Abilities in People With PTEN Germline Mutations (NCT06080165) | Stanford University | 2024-07-01 |
| Modified Periosteal Inhibition with Simultaneous Implant Placement in Aesthetic Zone (NCT06519773) | Tanta University | 2024-07-01 |
| Efficacy and Safety of HAIC in Combination With TQB2868 and Ramucirumab for Second-line Treatment of Advanced Hepatocellular Carcinoma (NCT06441019) | Fudan University | 2024-07-01 |
| Safety and Effectiveness of the PXL-Platinum 330 System for Cornea Crosslinking in Eyes With Cornea Thinning (NCT05516004) | Cohen Laser and Vision Center | 2024-07-01 |
| Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR Mutant Advanced NSCLC-RW (NCT06355609) | Hunan Province Tumor Hospital | 2024-07-01 |
| A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial). (NCT05895136) | European Foundation for Study of Chronic Liver Failure | 2024-07-01 |
| Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC (NCT06456138) | Shanghai Chest Hospital | 2024-07-01 |
| The Efficacy and Safety of Tofacitinib in Patients With Glucocorticoid Resistant ICIs-related Myocarditis (NCT06393972) | Shanghai Zhongshan Hospital | 2024-07-01 |
| Aromatherapy in the Treatment of Early Breast Cancer (NCT06435104) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2024-07-01 |
| Effect of Single-versus Double-limb Cycling Exercise on Blood Flow in Patients With Peripheral Artery Disease (NCT06518590) | Cairo University | 2024-07-01 |
| Zanubrutinib and G-CHOP in Untreated Intermediate-high Risk Follicular Lymphoma (NCT06474481) | Tianjin Medical University Cancer Institute and Hospital | 2024-07-01 |
| Combination of Steroid and Humanized CD25 Monoclonal Antibody as First-line Therapy for aGVHD (NCT06473909) | Institute of Hematology & Blood Diseases Hospital, China | 2024-07-01 |
| A Study of Cadonilimab（AK104）Combined With Standard Treatment for Function Preservation in Urinary System Tumors (NCT06427057) | Tongji Hospital | 2024-07-01 |
| Cardiovascular Genistein Therapy for Heart Failure Inflammation (NCT06501768) | University Medical Centre Ljubljana | 2024-07-01 |
| Early Resuscitation in Paediatric Sepsis Using Inotropes (NCT06478797) | NATALIA LOPERA MUNERA | 2024-07-01 |
| Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer. (NCT06492421) | Second Affiliated Hospital of Guangzhou Medical University | 2024-07-01 |
| Safety and Efficacy of Autologous Tumor-infiltrating Lymphocytes Therapy in Patients With Hepatocellular Carcinoma (NCT06463522) | Beijing 302 Hospital | 2024-07-01 |
| Individualized Radiation Dose Prescription in HNSCC Based on F-MISO-PET Hypoxia-Imaging (NCT03865277) | Technische Universität Dresden | 2024-07-01 |
| Luminal Fructose Kinetics (MARTINI Study) (NCT06539494) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2024-07-01 |
| Efficacy and Safety of SCT650C in Participants With Axial Spondyloarthritis (NCT06197009) | Sinocelltech Ltd. | 2024-07-01 |
| Visual-acoustic Intervention With Service Delivery In-person and Via Telepractice Trial (NCT06517225) | New York University | 2024-07-01 |
| Consolidative Radiotherapy (CSRT) in Patients With Oligometastatic/Locally Advanced Unresectable Bilary Tract Cancer (BTC) (NCT06502080) | Shanghai Zhongshan Hospital | 2024-07-01 |
| The Use of Dexamethasone in Total Thyroidectomy to Improve Voice Outcome and Hypocalcaemia (NCT05732883) | Tseung Kwan O Hospital, Hong Kong | 2024-07-01 |
| Furmonertinib Combined With Anlotinib in Lung Adenocarcinoma Patients With EGFR Mutations and Brain Metastases (NCT06483672) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-07-01 |
| Preoperative HFRT Verses PULSAR for Locally Advanced GEJ or Proximal Gastric Adenocarcinoma (NCT06728657) | Fudan University | 2024-07-01 |
| TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors (NCT06500091) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2024-07-01 |
| SHR-8068 in Combination With Adebrelimab, Bevacizumab, and Platinum-Based Chemotherapy as First-line Treatment in Patients With Advanced Biliary Tract Cancer (NCT06465563) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2024-07-01 |
| RQC for the Prevention of Alzheimer's Disease and Retinal Amyloid-β (NCT06470061) | Zaparackas and Knepper LTD | 2024-07-01 |